@inproceedings{inproceedings, title  = {{CARDINALS: A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Utreloxastat (PTC857) in Patients with Amyotrophic Lateral Sclerosis (P5-11.010)}},

 publisher = {{Ovid Technologies (Wolters Kluwer Health)}},

 url = {{http://dx.doi.org/10.1212/wnl.0000000000205241 }},

 year = {{2024}},

 month = {{4}},

 author = {{Katz JS and Vu T and Chio A and McDermott C and Devos D and Johnston M and Sierra R and Tansy A and Trimmer J and Shefner JM}},

 doi = {{10.1212/wnl.0000000000205241}},

 volume = {{102}},

 journal = {{Neurology}},

 issue = {{17_supplement_1}},

 note = {{Accessed on 2024/10/19}}}